Want to see HLTHQ full AI Analyst Report?

Cue Health (HLTHQ) Price & Analysis

225 Followers

HLTHQ Stock Chart & Stats

$0.04

$0.00(0.00%)

At close: Jan 08 4:00 PM EST

$0.04

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.04 - $0.74

Previous CloseN/A

Volume352.00

Average Volume (3M)N/A

Market Cap

$159.00

Enterprise Value-$32.95M

Total Cash (Recent Filing)$81.69M

Total Debt (Recent Filing)$47.94M

Price to Earnings (P/E)―

Beta73.57

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding159,091,810

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.10

Price to Sales (P/S)0.39

P/FCF Ratio-0.16

Enterprise Value/Market Cap-207.22K

Enterprise Value/Revenue-0.46

Enterprise Value/Gross Profit0.59

Enterprise Value/Ebitda0.11

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Equity BaseA strong equity base provides financial stability and can help the company weather financial challenges, supporting long-term resilience.

Revenue Model DiversificationDiversified revenue streams from products, partnerships, and subscriptions can enhance revenue stability and growth potential over time.

Innovative Product OfferingInnovative diagnostic solutions can drive market differentiation and customer loyalty, supporting long-term competitive advantage.

Bears Say

Significant Revenue DeclineA sharp revenue decline indicates potential market challenges and can impact the company's ability to invest in growth and innovation.

Negative Profit MarginsDeeply negative profit margins highlight operational inefficiencies and can strain financial resources, affecting long-term sustainability.

Cash Flow ChallengesNegative cash flow ratios indicate liquidity issues, which can limit the company's ability to fund operations and growth initiatives.

HLTHQ FAQ

What was Cue Health’s price range in the past 12 months?

Cue Health lowest stock price was $0.04 and its highest was $0.74 in the past 12 months.

What is Cue Health’s market cap?

Cue Health’s market cap is $159.00.

When is Cue Health’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Cue Health’s earnings last quarter?

Currently, no data Available

Is Cue Health overvalued?

According to Wall Street analysts Cue Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cue Health pay dividends?

Cue Health does not currently pay dividends.

What is Cue Health’s EPS estimate?

Cue Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cue Health have?

Cue Health has 159,091,810 shares outstanding.

What happened to Cue Health’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Cue Health?

Currently, no hedge funds are holding shares in HLTHQ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cue Health

Cue Health Inc. functioned as a healthcare technology company, developing the Cue Health platform to provide individuals and healthcare providers with convenient and personalized access to lab-quality diagnostic tests, usable both at home and at the point-of-care. The platform also enabled on-demand telehealth consultations and offered treatment options for various health and wellness needs. Its core offering, the Cue Integrated Care platform, comprised essential hardware components like the Cue Health Monitoring System (featuring a reusable Cue Reader, a single-use Cue Cartridge, and a Cue Wand), sophisticated software including the cloud-based Cue Data and Innovation Layer for analytics, and virtual care delivery applications such as the Cue Health App and Cue Enterprise Dashboard. The platform also integrated with a broader ecosystem, connecting to electronic medical record systems, pharmacies, last-mile delivery services, clinician networks, and laboratories. Additionally, the company supplied COVID-19 testing kits. Founded in 2010 in San Diego, California, the firm was formerly known as Cue Inc. until its name change in December 2017. However, on May 28, 2024, Cue Health Inc. and its affiliates initiated voluntary liquidation by filing for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.